Timothy J. Wilt - Profile and Journalist Details

Find journalists that align with your industry, location and vision. Unlock Timothy J. Wilt's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.

Get connected with journalists today
Timothy J. Wilt

Timothy J. Wilt

Verified

Contributor, Annals of Internal Medicine

Beats

Primary beats

Doesn’t Cover

children, weight loss, parenting

Journalist Type

Seniority Positions

Industries

-

Content

Total articles 38

  • Pharmacologic Treatments of Acute Episodic Migraine Headache in Outpatient Settings: A Clinical Guideline From the American College of Physicians

    By Amir Qaseem, Jeffrey A. Tice, Itziar Etxeandia-Ikobaltzeta, Timothy J. Wilt| Annals of Internal Medicine Verified Migraine is a prevalent and disabling condition, ranking as the second leading cause of global disability (expressed as years lived with disability) in all adults and the top cause in females aged 15 to 49 years (1, 2). In the United States, migraine affects approximately 16% of people, and females are more affected than males (21% of females and 11% of males) (3).

    By Amir Qaseem, Jeffrey A. Tice, Itziar Etxeandia-Ikobaltzeta, Timothy J. Wilt · Annals of Internal Medicine

    Mar. 17, 2025

  • Impact of the diagnostic label for a low-risk prostate lesion: protocol for two online factorial randomised experiments

    By James Bullen, Brooke Nickel, Kirsten J McCaffery, Timothy J. Wilt| BMJ Open Verified Methods and analysisTwo separate online randomised studies of Australian residents will be run for men and for women. For both studies, participants will be randomised to receive one of three hypothetical scenarios about the diagnosis of a low-risk prostate cancer received by themselves or their partner. Participants within each label group are then randomised to high information or low information condition, referring to the level of detail presented about the possible management options.

    By James Bullen, Brooke Nickel, Kirsten J McCaffery, Timothy J. Wilt · BMJ Open

    Aug. 10, 2024

  • Pharmacologic Treatments of Acute Episodic Migraine Headache in Outpatient Settings: A Clinical Guideline From the American College of Physicians

    By Amir Qaseem, Jeffrey A. Tice, Itziar Etxeandia-Ikobaltzeta, Timothy J. Wilt| Annals of Internal Medicine Verified Migraine is a prevalent and disabling condition, ranking as the second leading cause of global disability (expressed as years lived with disability) in all adults and the top cause in females aged 15 to 49 years (1, 2). In the United States, migraine affects approximately 16% of people, and females are more affected than males (21% of females and 11% of males) (3).

    By Amir Qaseem, Jeffrey A. Tice, Itziar Etxeandia-Ikobaltzeta, Timothy J. Wilt · Annals of Internal Medicine

    Mar. 17, 2025

As seen in

Company Info

Annals of Internal Medicine